Cure Breast Cancer Foundation’s Annual ‘Lease for a Cure’ Embraced by Community-Minded Real Estate Companies
Lease for a Cure, a fundraising program that invites the real estate industry to participate in important breast cancer research, has caught the eye of multifamily property owners and related industry vendors looking to make a difference in the communities and fields they serve.
Clifton, N.J.—Lease for a Cure, a fundraising program that invites the real estate industry to participate in important breast cancer research, has caught the eye of multifamily property owners and related industry vendors looking to make a difference in the communities and fields they serve.
Sponsored by the Cure Breast Cancer Foundation (CBCF), a non-profit 501 (c) 3 organization, the annual month long event has raised significant funds in the past two years to support the research efforts of Dr. Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs and the Medical Director of the Evelyn H. Lauder Breast Center at Memorial Sloan- Kettering Cancer Center, and his colleagues.
Every year Lease for a Cure has added more and more prominent apartment owners and related industry companies to its list of participants, resulting in fundraising efforts that annually surpass the previous year. In 2010, the initial Lease For A Cure event totaled more than $25,000 in donations, a number that grew in the 2011 2nd Annual program. More than 20 companies participated in the 2011 2nd Annual Lease For A Cure campaign.
Held during National Breast Cancer Awareness month, participants in Lease For A Cure donate $10 to the CBCF for every new lease signed and $20 for every renewal signed at their rental communities throughout October, and vendors participating donate per project.
Since its inception in December 2007, CBCF has raised in excess of $4 Million through events such as the annual Golf Classic, walk-a-thons, fashion shows and other fundraising activities. Fully 100% of its net fundraising proceeds received by the foundation are donated to the Memorial Sloan-Kettering Cancer Center in Manhattan and other national and international cancer research facilities to support the groundbreaking research being conducted under the direction of Dr. Larry Norton and his colleagues.
To take part in this year’s effort, please call (973) 471-CBCF (2223) or email [email protected] for additional information and to register for this year’s program.
